Gene · 9235
Papers3,054
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,054
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advanced-stage cutaneous T-cell lymphomas show distinct immune profiles in erythroderma vs. tumor lesions. | J Dermatol Sci | 2026 | 42810908 | PubTator, text mining | PubMed |
| Mitochondrial DNA Released by Biliary Epithelial Cells Enhances Inflammation in Biliary Atresia Through the Cyclic GMP-AMP Synthase-Stimulator of Interferon Genes-Nuclear Factor-κB Pathway. | Cell Mol Gastroenterol Hepatol | 2026 | 42785431 | PubTator, text mining | PubMed |
| IL-32 drives PR3-dependent NET formation to promote portal vein tumor thrombosis and radioresistance in HCC. | Transl Oncol | 2026 | 42767097 | PubTator, text mining | PubMed |
| A Shared EGR1-IL-32-Macrophage Polarisation Signature in Rheumatoid Arthritis and Metabolic Dysfunction-Associated Steatotic Liver Disease. | J Inflamm Res | 2026 | 42703413 | PubTator, text mining | PubMed |
| Multimodal analysis of CD38 in T-cell Acute Lymphoblastic Leukemia Identifies Combinatorial Therapeutic Strategies. | Blood | 2026 | 42685004 | PubTator, text mining | PubMed |
| Dynamic integration of CXCL8 or CCL20 signaling with IL-15 or IL-32α reprograms human T-cell functional plasticity. | Front Immunol | 2026 | 42682451 | PubTator, text mining | PubMed |
| BRD4 contributes to the cytokine-induced acquisition of an IL-13RA2-positive inflammatory fibroblast phenotype. | J Crohns Colitis | 2026 | 42635600 | PubTator, text mining | PubMed |
| Stage-Specific Reduction of Serum IL-32 in Secondary Syphilis and Associations with Lipid Metabolism Parameters. | Diagn Microbiol Infect Dis | 2026 | 42632155 | PubTator, text mining | PubMed |
| Serum IL-32γ as a biomarker for remission assessment in systemic lupus erythematosus. | Front Immunol | 2026 | 42620248 | PubTator, text mining | PubMed |
| Single-cell profiling reveals IFI44L as a central regulator of immune dysregulation in high HIV viral load. | Med Microbiol Immunol | 2026 | 42606736 | PubTator, text mining | PubMed |
| [Associations of candidate gene polymorphisms, gut microbiota, and their interactions with NAFLD in obese children]. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2026 | 42565570 | PubTator, text mining | PubMed |
| CCL20-CCR6 axis mediates mucosal-associated invariant T-M2 macrophage crosstalk to drive immune dysregulation in liver cirrhosis. | Front Immunol | 2026 | 42548584 | PubTator, text mining | PubMed |
| Intracellular pathogen targeting by IL32 elicits cell-autonomous immunity. | bioRxiv | 2026 | 42539167 | PubTator, text mining | PubMed |
| The Framework of Host Innate and Adaptive Immunological Pathways. | Biomedicines | 2026 | 42512102 | PubTator, text mining | PubMed |
| Interleukin 32 Expression in Mesothelioma. | Thorac Cancer | 2026 | 42452982 | PubTator, text mining | PubMed |
| Single-cell profiling reveals a novel CAF subpopulation linking stromal heterogeneity to immune suppression in breast cancer subtypes. | J Transl Med | 2026 | 42351142 | PubTator, text mining | PubMed |
| Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. | Neurol Neuroimmunol Neuroinflamm | 2026 | 42335444 | PubTator, text mining | PubMed |
| Pharmacological and genetic modulation of IL-32 expression in intestinal epithelial cells does not impact HIV-1 outgrowth in co-cultured CD4+ T-cells. | Front Immunol | 2026 | 42273706 | PubTator, text mining | PubMed |
| Evaluating Multifactorial Contributors to Metabolic Syndrome in Western Mexico: The Role of Metabolic Age, Lifestyle, and IL32 rs45499297 Polymorphism. | Endocr Metab Immune Disord Drug Targets | 2026 | 42257262 | PubTator, text mining | PubMed |
| Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis. | Nat Genet | 2026 | 42151416 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9235/papers